GRI Bio Announces Reverse Stock Split

Yahoo Finance Published Updated Economy
Sign in to save

Why it matters

GRI Bio, a biotechnology company, announced a 1-for-28 reverse stock split, effective January 26, 2026, aiming to increase the company's stock price and potentially improve its market presence.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Bullish Confidence 80% How confidence is read Horizon: Short term Impact: Moderate

Market impact analysis based on bullish sentiment with 80% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim GRI Bio Announces Reverse Stock Split
AI inference Bullish · 80%
Generated 2026-01-21 21:01

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
35525

Original source

GRI’s common stock is expected to begin trading on a post-split adjusted basis on January 26, 2026 LA JOLLA, CA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that the board of directors of the Company approved a 1-for-28 reverse stock split (the “Reverse Split”) of the Company’s commo

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on January 22, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage